Mitochondrial ROS control neuronal excitability and cell fate in frontotemporal dementia.
Noemí EsterasOlga KopachMarta MaiolinoVincenzo LaricciaSalvatore AmorosoSeema QamarSelina WrayDmitri A RusakovMorana JaganjacAndrey Y AbramovPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2021)
These results demonstrate mitochondrial ROS modulate glutamatergic signaling in FTD, and suggest a new therapeutic strategy.